Clinical Study on the Prevention of Oxaliplatin-Induced Neurotoxicity with Guilongtongluofang: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Table 1

Basic characteristics of study population.

Characteristics	Trial group (𝑛, %); (𝑛=60)	Control group (𝑛, %); (𝑛=60)	𝑃 value
Age (years)
≥50	10 (16.7)	7 (11.7)	0.83
<50	50 (83.3)	53 (88.3)
Gender
Male	43 (71.7)	40 (66.7)	0.55
Female	17 (28.3)	20 (33.3)
Performance status
0	34 (56.7)	29 (48.3)	0.36
1,2	26 (43.3)	31 (51.7)
Location of primary tumor
Colon	32 (53.3)	34 (56.7)	0.74
Rectum	28 (46.7)	26 (43.3)
Histological differentiation
Well/moderately	45 (75.0)	41 (68.3)	0.41
Poorly/unknown	15 (25.0)	19 (31.7)
Sites of distant metastasis
Liver	12 (20.0)	10 (16.7)	0.74
Lung	8 (13.3)	8 (13.3)
Liver and lung	4 (6.7)	3 (5.0)
Others	0	1 (1.7)